FDA approves Abilify tablets with ingestible sensor

FDA approved Abilify MyCite, which combines the antipsychotic Abilify aripiprazole from Otsuka Pharmaceutical Co. Ltd. (Tokyo, Japan) with an ingestible sensor from Proteus Digital Health

Read the full 259 word article

User Sign In